1 From the Division of Perinatal Medicine, Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY.
2 From the Department of Otolaryngology, College of Physicians and Surgeons, Columbia University, New York, NY.
Thirty-four infants who had a diagnosis of severe persistent pulmonary hypertension of the newborn at birth (alveolar-arterial oxygen difference > 600) were treated without paralysis or hyperventilation to induce alkalosis. All survived. Twenty-seven of these 34 eligible infants (79%) underwent neurologic, intelligence, and audiologic testing between 10 months and 6 years of age. Children who were younger than 1 year of age at the initial hearing test were retested after they reached 2 years of age. The average IQ was within the normal range (mean = 96.23). None had sensorineural hearing loss. Severe neurologic abnormalities were seen in 4 children, 3 of whom had been severely asphyxiated at birth (determined by biochemical criteria). Mild neurologic abnormalities were observed in 5 children. Two infants had bronchopulmonary dysplasia because they required supplemental oxygen for 29 and 66 days, respectively, and had abnormal chest roentgenograms; 1 patient takes intermittent doses of albuterol (Ventolin) and neither currently requires supplemental oxygen. This study of 27 infants with severe persistent pulmonary hypertension of the newborn suggests that conservative management without induced alkalosis or respiratory paralysis is accompanied by no sensorineural hearing loss and a good neurologic outcome.
Key Words: persistent pulmonary hypertension of the newborn extracorporeal membrane oxygenation hearing loss neurodevelopmental outcome
Submitted on October 22, 1990
Accepted on February 25, 1992
This article has been cited by other articles:
![]() |
M. Ellington Jr, D. O'Reilly, E. N. Allred, M. C. McCormick, D. L. Wessel, and S. Kourembanas Child Health Status, Neurodevelopmental Outcome, and Parental Satisfaction in a Randomized, Controlled Trial of Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn Pediatrics, June 1, 2001; 107(6): 1351 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hutchin, C. Gilmer, and W. G. Yarbrough Delayed-Onset Sensorineural Hearing Loss in a 3-Year-Old Survivor of Persistent Pulmonary Hypertension of the Newborn Arch Otolaryngol Head Neck Surg, August 1, 2000; 126(8): 1014 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meyer, J. Witte, A. Hildmann, K.-H. Hennecke, K.-U. Schunck, K. Maul, U. Franke, H. Fahnenstich, H. Rabe, R. Rossi, et al. Neonatal Screening for Hearing Disorders in Infants at Risk: Incidence, Risk Factors, and Follow-up Pediatrics, October 1, 1999; 104(4): 900 - 904. [Abstract] [Full Text] |
||||
![]() |
R. D. Eavey, M. d. C. C. Bertero, A. R. Thornton, B. S. Herrmann, J. M. Joseph, R. E. Gliklich, K. S. Krishnamoorthy, and I. D. Todres Failure to Clinically Predict NICU Hearing Loss Clinical Pediatrics, March 1, 1995; 34(3): 138 - 145. [Abstract] [PDF] |
||||